The Relative Cost-Effectiveness of Anticoagulants Obvious, Except for the Cost and the Effectiveness

被引：29

作者：

Avorn, Jerry ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA

[2] Harvard Univ, Sch Med, Boston, MA 02120 USA

来源：

CIRCULATION | 2011年 / 123卷 / 22期

关键词：

anticoagulants; cost-effectiveness; economics; warfarin; ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; DABIGATRAN; EVENTS;

D O I：

10.1161/CIRCULATIONAHA.111.030148

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2519 / 2521

页数：3

共 16 条

[1] Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran
Agnelli, G.
Eriksson, E. L.
Cohen, A. T.
Bergqvist, D.
Dahl, O. E.
Lassen, M. R.
Mouret, P.
Rosencher, N.
Andersson, M.
Bylock, A.
Jensen, E.
Boberg, B.
[J]. THROMBOSIS RESEARCH, 2009, 123 (03) : 488 - 497
[2] Developing the Sentinel System - A National Resource for Evidence Development
Behrman, Rachel E.
Benner, Joshua S.
Brown, Jeffrey S.
McClellan, Mark
Woodcock, Janet
Platt, Richard
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) : 498 - 499
[3] Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation
Birman-Deych, E
Radford, MJ
Nilasena, DS
Gage, BF
[J]. STROKE, 2006, 37 (04) : 1070 - 1074
[4] Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
Choudhry, NK
Anderson, GM
Laupacis, A
Ross-Degnan, D
Normand, SLT
Soumerai, SB
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7534): : 141 - 143
[5] Newly Identified Events in the RE-LY Trial
Connolly, Stuart J.
Ezekowitz, Michael D.
Yusuf, Salim
Reilly, Paul A.
Wallentin, Lars
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) : 1875 - 1876
[6] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Connolly, Stuart J.
Ezekowitz, Michael D.
Yusuf, Salim
Eikelboom, John
Oldgren, Jonas
Parekh, Amit
Pogue, Janice
Reilly, Paul A.
Themeles, Ellison
Varrone, Jeanne
Wang, Susan
Alings, Marco
Xavier, Denis
Zhu, Jun
Diaz, Rafael
Lewis, Basil S.
Darius, Harald
Diener, Hans-Christoph
Joyner, Campbell D.
Wallentin, Lars
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
[7] Freeman JV, 2011, ANN INTERN MED, V154, P570, DOI 10.7326/0003-4819-154-8-201104190-00014
[8] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
Freeman, James V.
Zhu, Ruo P.
Owens, Douglas K.
Garber, Alan M.
Hutton, David W.
Go, Alan S.
Wang, Paul J.
Turakhia, Mintu P.
[J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (01) : 1 - U129
[9] Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Hart, Robert G.
Pearce, Lesly A.
Aguilar, Maria I.
[J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) : 857 - 867
[10] Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: Results of a survey of long-term care practitioners
Monette, J
Gurwitz, JH
Rochon, PA
Avorn, J
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1060 - 1065

← 1 2 →